Gerald Solensky Jr.

Gerald Solensky Jr. is a declared insider of Zomedica Pharmaceuticals Corp., with filings sourced from SEDI. Between 19 December 2017 and 29 March 2019, the trades on record add up to 6 filings.

No open-market purchase appears, only 1 sale worth €268. Besides market trades, the filings include 5 option exercises. 2019 to date brings no purchases and 1 sale.

The newest entry dates from 2 April 2019: an option exercise of €89k, in Zomedica Pharmaceuticals Corp. Typically, a trade is published a median of 4 days after it takes place. That lag is the time during which only the insider knows about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.